Display options
Cite
Dombret H, Hunault M, Faucher C, et al. Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils. Cancer. 1992;69(6):1356-61doi: 10.1002/1097-0142(19920315)69:6<1356::aid-cncr2820690609>3.0.co;2-b.
Dombret, H., Hunault, M., Faucher, C., Dombret, M. C., & Degos, L. (1992). Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils. Cancer, 69(6), 1356-61. https://doi.org/10.1002/1097-0142(19920315)69:6<1356::aid-cncr2820690609>3.0.co;2-b
Dombret, H, et al. "Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils." Cancer vol. 69,6 (1992): 1356-61. doi: https://doi.org/10.1002/1097-0142(19920315)69:6<1356::aid-cncr2820690609>3.0.co;2-b
Dombret H, Hunault M, Faucher C, Dombret MC, Degos L. Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils. Cancer. 1992 Mar 15;69(6):1356-61. doi: 10.1002/1097-0142(19920315)69:6<1356::aid-cncr2820690609>3.0.co;2-b. PMID: 1540873.
Copy Download .nbib Format: NLM
Share it on

Cancer. 1992 Mar 15;69(6):1356-61. doi: 10.1002/1097-0142(19920315)69:6<1356::aid-cncr2820690609>3.0.co;2-b.

Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils.

Cancer

H Dombret, M Hunault, C Faucher, M C Dombret, L Degos

Affiliations

  1. Service Clinique des Maladies du Sang, Hopital Saint-Louis, Paris, France.

PMID: 1540873 DOI: 10.1002/1097-0142(19920315)69:6<1356::aid-cncr2820690609>3.0.co;2-b

Abstract

Acute respiratory failure developed in two patients with hyperleukocytic acute myelomonocytic leukemia with abnormal marrow eosinophils within 1 to 3 days after the beginning of high-dose induction chemotherapy. The presence of moderate pulmonary leukostasis before chemotherapy initiation, the simultaneous occurrence of an acute tumor lysis syndrome, the lack of evidence of any other cause of respiratory distress, and the clinical evolution lead the authors to attribute pulmonary injury to lysis of resident leukemic cells. The responsibility of eosinophilic cellular constituents for the diffuse alveolar damage is discussed.

Similar articles

Cited by

Substances

MeSH terms

Publication Types

LinkOut - more resources